Single Use Ureteral Access Sheath
Zhejiang Chuangxiang Medical Technology Co., Ltd. · Decision date Sep 11, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-09-11 for K260410, a Single Use Ureteral Access Sheath submitted by Zhejiang Chuangxiang Medical Technology Co., Ltd. The submission was received on 02/09/2026 and reviewed under product code FED, with Gastroenterology/Urology as both the regulation medical specialty and the 510(k) review panel. The record lists the review type as Special and states that it was not reviewed by a third party.
A SESE decision is a 510(k) clearance finding, not premarket approval of the device. The available record does not identify a predicate device, summarize the technological characteristics compared with any predicate, or describe performance testing, so the basis for the equivalence finding is not established here. One excerpt references an endoscopic access overtube classification, which does not match the ureteral access sheath device name; the record does not resolve that discrepancy.
Details on materials, dimensions, indications for use, and any labeling remain outside the retrieved fields and would need the underlying FDA documents.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Sep 11, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260410
- Regulatory pathway
- 510(k) premarket notification
- Product code
- FED
- Decision code
- SESE
- Decision date
- Sep 11, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Endoscopic Access Overtube, Gastroenterology-Urology.
- Product code
- FED
- FDA device class
- 2
FDA decision timeline
K260410 received
Application receipt date recorded by FDA.
K260410 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code FED
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Yangzhou Fartley Medical Instrument Technology Co., Ltd. | 510(k) clearance | Sep 21, 2026 | FDA | |
| NEPTUNE MEDICAL INC. | 510(k) clearance | Sep 18, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Zhejiang Chuangxiang Medical Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Hangzhou
Sources and methodology
- Original FDA record: K260410
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
